In estrogen receptor α (ERα), positive endometrial and breast cancer cell lines E2 can increase PD-L1 protein expression via the phosphoinositide 3 kinase (PI3K)/Akt pathway and post-transcriptional PD-L1 mRNA stabilization [45]. This evidence concerns the gene ESR1 and breast carcinoma.